Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells

Kristin Kee1, Slavoljub Vujcic, Salim Merali

  • 1Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

Insights

Activating polyamine catabolism via spermidine/spermine N(1)-acetyltransferase (SSAT) in prostate cancer cells inhibits growth. This occurs through metabolic flux, not polyamine depletion, highlighting a unique cancer vulnerability.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Intracellular polyamine depletion inhibits cell growth.
  • Spermidine/spermine N(1)-acetyltransferase (SSAT) activation is a strategy to inhibit cell growth.
  • Prostate cancer cells may exhibit unique polyamine homeostasis, suggesting sensitivity to SSAT activation.

Purpose of the Study:

  • To investigate the sensitivity of prostate cancer cells (LNCaP) to activated polyamine catabolism via SSAT.
  • To elucidate the mechanisms underlying SSAT-induced growth inhibition in prostate cancer cells.

Main Methods:

  • Conditional overexpression of SSAT in LNCaP cells using a tetracycline-regulatable (Tet-off) system.
  • Measurement of SSAT mRNA, enzyme activity, and polyamine levels.
  • Assessment of cell growth inhibition and metabolic flux through polyamine biosynthesis and catabolism pathways.

Main Results:

  • SSAT induction in LNCaP cells led to rapid increases in SSAT mRNA and enzyme activity.
  • SSAT activation resulted in growth inhibition without polyamine depletion, unlike in MCF-7 cells.
  • LNCaP cells exhibited compensatory increases in ornithine decarboxylase and S-adenosylmethionine decarboxylase, maintaining polyamine levels but increasing metabolic flux.
  • Inhibition of polyamine biosynthesis during SSAT induction prevented growth inhibition, suggesting flux-induced toxicity.

Conclusions:

  • Activation of polyamine catabolism in LNCaP cells triggers compensatory polyamine biosynthesis, leading to significant metabolic flux.
  • This flux, rather than polyamine depletion, causes growth inhibition in prostate cancer cells.
  • Targeting polyamine metabolism, specifically SSAT, presents a potential therapeutic strategy for prostate cancer.